Common Ailments and Certain Conditions

Pharmacists who are authorized by the College may prescribe drugs, treatments or devices for conditions listed under the Common Ailments, Preventable Conditions, and Chronic Conditions sections below.  

A notation is included next to the pharmacy professional’s name and registration number in the College’s public register (Find a professional). 

Please note the information below was updated as of February 2026.

Pharmacists may prescribe Schedule I, Schedule II, Schedule III and Unscheduled medications for the treatment of the following. Contents of this list of Common Ailments reflects what was in the first Section of Appendix 2 to the Regulations, prior to May, 2025.

 

  • Allergic Rhinitis 
  • Calluses and Corns 
  • Conjunctivitis (allergic and bacterial) 
  • Contact Allergic Dermatitis 
  • Dandruff 
  • Dysmenorrhea 
  • Dyspepsia
  • Emergency Contraception 
  • Fungal Infections of the Skin 
  • Gastro-esophageal Reflux Disease 
  • Group A streptococcal (GAS) pharyngitis (Guidance)
  • Hemorrhoids
  • Herpes Simplex 
  • Herpes Zoster (shingles) (Guidance)
  • Impetigo 
  • Mild Acne 
  • Mild Headache 
  • Mild to Moderate Eczema 
  • Mild Urticaria (including bites and stings) 
  • Minor Joint Pain 
  • Minor Muscle Pain 
  • Minor Sleep Disorders 
  • Nausea
  • Nicotine dependence 
  • Non-infectious Diarrhea 
  • Oral Fungal Infection (thrush) 
  • Oral Ulcers 
  • Severe Acute Respiratory Syndrome (SARS) 
  • Threadworms and Pinworms 
  • Upper respiratory tract symptoms (cough, nasal congestion and discharge, sore throat, fever, malaise) 
  • Urinary Tract Infection (uncomplicated) 
  • Vaginal Candidiasis 
  • Warts (excluding facial and genital) 
  • Xerophthalmia (dry eyes)  

Pharmacists may prescribe Schedule I, Schedule II, Schedule III and Unscheduled vaccines (individual or combination products) and/or drug products for the prevention of the following. Contents of this list of preventable conditions reflects what was in the second section of Appendix 2 to the Regulations, prior to May, 2025.

  • Cholera (pharmacist may prescribe only the oral, inactivated vaccine)
  • Diphtheria
  • Haemophilus influenzae type B
  • Hepatitis A
  • Hepatitis B
  • Herpes Zoster (shingles) 
  • Human Papillomavirus (HPV)
  • Lyme Disease (Guidance)
  • Malaria
  • Measles
  • Meningococcal disease
  • Mumps
  • Pertussis
  • Pneumococcal Disease
  • Polio
  • Pregnancy (oral, transdermal, transvaginal and injection hormonal drug products) (Guidance)
  • Respiratory Syncytial Virus (RSV) (Guidance)
  • Rubella
  • Seasonal Influenza
  • Severe Acute Respiratory Syndrome (SARS)
  • Tetanus
  • Traveler’s Diarrhea (pharmacist may also prescribe pre-emptive treatment)
  • Varicella zoster (chickenpox)

Pharmacists may only prescribe vaccines for the following travel-related diseases upon successful completion of a training program in travel medicine approved by Council. Contents of this list of preventable conditions reflects what was in the second section of Appendix 2 to the Regulations, prior to May, 2025.

 

  • Cholera (other than the oral, inactivated vaccine)
  • European tick-borne encephalitis
  • Japanese encephalitis
  • Rabies
  • Typhoid
  • Yellow fever

Pharmacists may assess and prescribe treatment for the following Chronic Diseases ONLY if practicing at one of the pharmacies authorized to assess and treat these conditions:

  • Asthma 
  • Cardiovascular Disease 
  • Chronic Obstructive Pulmonary (COPD) 
  • Diabetes

Authorized pharmacies

Familiprix, 1074 Rue du Parc, Paquetville, NB

Jean Coutu, 438 Coverdale Rd., Riverview, NB

Lawtons Drugs, Brookside Mall, 435 Brookside Dr., Fredericton, NB

The Medicine Shoppe, 1685 Main St., Moncton, NB

Pharmasave, 599 Main St., Hampton, NB

Shoppers Drug Mart, 1040 Prospect St., Fredericton, NB

The College accepts submissions for research or pilot projects designed to evaluate pharmacist-led assessment and prescribing in expanded pharmacy services for the public. The framework is in accordance with the Regulations and is provided in detail in the following guidance and supporting documents:  

Guidance for Prescribing in Accordance with a Research or Pilot Protocol:

↑ Back to top ↑

Secret Link